Pre-clinical studies demonstrated multiple advantages, including less patient variability, faster onset of action, shorter duration of effect, and improved brain penetration.
Compass Pathways (Nasdaq: CMPS) has announced the launch of a…
This trial, using Filament Health’s botanical drug candidates, is the first to assess the direct administration of psilocin.
Kate Kincaid, who specializes in psychedelic integration and ketamine-assisted therapy, appears on the premiere of our new series “Spotlight in Focus” to share parallels between labor and tripping on psychedelics.
Psychedelic Spotlight trips with Ram Dass at the 50th anniversary celebration of the spiritual teacher’s iconic book.
Pop star says in new interview that tripping on psilocybin enabled him, for the first time, to “write actual stories about my life and put it into my music.”
“Something that people used to speak about only in whispers is now standard policy,” says the psychedelics researcher, with 20 years of experience, in a wide-ranging Q&A.
A study of American newspaper mentions of psychedelics doesn’t stack up to what leaders in the industry are observing in the media landscape at large.
Researchers found stress further reduced for the participants that use psychedelic drugs at least once every six months.
From mind-expanding spice to honoring sacred medicine, Denis Villeneuve’s trippy new movie celebrates psychedelics throughout.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.